Product NewsUCB and UK’s MRC Technology Sign Exclusive License Agreement for a Fibrosis Program to Develop Antibody-Based Therapy
Industry NewsStudy Suggests Warfarin May Not be Most Effective Anticoagulant Treatment for Patients with Atrial Fibrillation
Product NewsNew Article by Spinnovation Biologics CEO Frederic Girard Details NMR For QbD Biologics Development
Product NewsDomain Therapeutics Enters into Collaboration with XOMA for GPCR-Directed Allosteric Modulator Antibody Screening
Industry NewsBioOutsource Announces the Opening of a New Biosimilar Centre of Excellence in Glasgow Due to a Surge in Global Demand
Product NewsMalvern Instruments’ 2014 Webinar Program Gets Underway with Light Scattering for Biopharma
Product NewsNanotherapeutics selects GE Healthcare Life Sciences technologies for Advanced Development and Manufacturing Center
Product NewsDon't Miss the Latest News from SLAS with SelectScience's Live Reports Direct from Conference
Industry NewsMeeting report: 2nd Innovation Academy Demonstrates the Impact Personalized Medicine is Having on Patient Outcomes Today
Product NewsMalvern Instruments Publishes New White Paper on ‘Developing a Bioformulation Stability Profile’ to Coincide with PepTalk 2014
Product NewsAdocia Launches Phase IIa Clinical Trial for its Ultra-Fast Acting Formulation of Analog Insulin
Product NewsWyatt Technology to Highlight Expertise in Characterizing Protein Formulations at PEPTALK 2014
Product NewsMerck Enters into License Agreement with the Spanish National Cancer Research Centre (CNIO)
Industry NewsGSTS Pathology Innovation Academy Demonstrates the Impact of Personalized Medicine Today
Product NewsIsraeli Drug Development Companies Are Poised for 505(b)(2) Development Process, Camargo Expert Says
Product NewsVentana Announces HER2 Companion Diagnostic to Identify Breast Cancer Patients for Roche's Latest Targeted Medicines
